|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/496 | (2006.01) |
| A61K 31/497 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 39/395 | (2013.01) | ||
| A61P 37/04 | (2006.01) | ||
| A61K 31/496 | (2013.01) |
| (11) | Patento numeris | 3372231 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16862109.2 |
| Europos patento paraiškos padavimo data | 2016-11-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-09-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-09-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2016/082536 |
| Data | 2016-11-02 |
| (87) | Numeris | WO 2017/078049 |
| Data | 2017-05-11 |
| (30) | Numeris | Data | Šalis |
| 2015217152 | 2015-11-04 | JP |
| (72) |
EGUCHI, Tomohiro , JP
YOSHIDA, Taku , JP
KADO, Ruriko , JP
|
| (73) |
Astellas Pharma Inc. ,
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku
Tokyo 103-8411,
JP
|
| (54) | PHARMACEUTICAL COMPOSITION FOR CANCER IMMUNOTHERAPY PURPOSES AND/OR IMMUNOSTIMULATION PURPOSES WHICH CONTAINS DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND AS ACTIVE INGREDIENT |
| PHARMACEUTICAL COMPOSITION FOR CANCER IMMUNOTHERAPY PURPOSES AND/OR IMMUNOSTIMULATION PURPOSES WHICH CONTAINS DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND AS ACTIVE INGREDIENT |